Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings.
Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings.
复制标题
DOI:
10.1136/bmjopen-2021-057588
复制
发表时间:
2022-06-16
期刊:
影响因子:
2.9
通讯作者:
Ali, Mohammed K.
中科院分区:
文献类型:
--
作者:
Suvada, Kara;Zimmer, Anna;Soodalter, Jesse;Malik, Jimi S.;Kavalieratos, Dio;Ali, Mohammed K.
Describe trends in opioid plus high-risk medication coprescribing in the USA. Analyses of serial, cross-sectional, nationally representative data of the National Ambulatory Medical Care Survey (NAMCS) over 2007–2016 and the National Hospital Ambulatory Medical Care Survey (NHAMCS) over 2007–2018. US ambulatory (NAMCS) and emergency department (ED, NHAMCS) settings. Patient visits in which the patient was 18 years and older with an opioid prescription in the NAMCS or NHAMCS databases. Frequency of opioid plus high-risk medication coprescribing. From a combined sample of 700 499 visits over 2007–2018, there were 105 720 visits (15.1%) where opioids were prescribed. n=31 825 were from NAMCS and n=73 895 were from NHAMCS. The mean prevalence of coprescription of opioids and high-risk medications for the combined NAMCS and NHAMCS sample was 18.4% in 2007, peaked at 33.2% in 2014 and declined to 23.8% in 2016. Compared with adults receiving opioid prescriptions alone, those coprescribed opioids and high-risk medications were older, more likely female, white and using private or Medicare insurance (p<0.0001). Coprescribing is more common in ambulatory than ED settings and has been declining, yet one in four patient visits where opioids were prescribed resulted in coprescribed, high-risk medications in 2016. Efforts and research to help lower the rates of high-risk prescribing are needed.
登录
查看更多内容
影响因子:
3.1
作者:
Dasgupta, Nabarun;Funk, Michele Jonsson;Marshall, Steve
通讯作者:
Marshall, Steve
影响因子:
9.7
作者:
Dowell, Deborah;Zhang, Kun;Hockenberry, Jason M.
通讯作者:
Hockenberry, Jason M.
影响因子:
3.1
作者:
Cochella, Susan;Bateman, Kim
通讯作者:
Bateman, Kim
DOI:
10.1001/jama.2016.1464
发表时间:
2016-04-19
期刊:
JAMA
影响因子:
--
作者:
Dowell D;Haegerich TM;Chou R
通讯作者:
Chou R
影响因子:
2
作者:
Heins, Sara E.;Sorbero, Mark J.;Stein, Bradley D.
通讯作者:
Stein, Bradley D.